Clinical Trial Update: Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study [Phase 3]

View source ↗

Summary

Phase 3 open-label, long-term study of balsalazide disodium tablet for ulcerative colitis completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• balsalazide disodium tablet (balsalazide disodium)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Inflammatory Bowel Disease, Ulcerative Colitis | Phase 3 | Status: COMPLETED | Results posted: 2018-01-19